Lisinopril Tablet
Product Images NDC 55289-884

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 55289-884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

133b3fec 07f6 41f5 9c7c 50b66c4c0677 01

133b3fec 07f6 41f5 9c7c 50b66c4c0677 01
Chemical structure of Lisinopril dihydrate, showing the molecular arrangement including functional groups and connectivity consistent with the active ingredient Lisinopril.*
FDA Label Image

55289884 Label (55289884)

55289884 Label (55289884)
Label for Lisinopril USP 5 mg oral tablets by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. The label shows a 30-tablet packaging with NDC 55289-884-30, reorder number 100337, and sample lot with expiration 01/50. It includes barcode, QR code, dosage instructions blanks, and a green warning bar to keep out of reach of children. Directions and adverse effect reporting info are partially visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.